About us

Ophidion, Inc. is an early-stage CNS biopharmaceutical company built around a proprietary, non-invasive carrier technology that enables direct delivery of gene-silencing agents and other therapeutics across the blood-brain barrier into the brain. This platform is the foundation for a pipeline of disease-modifying and symptomatic treatments for serious, progressive neurodegenerative diseases.